Affibody AB
556665-6913ActiveDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Overview
- 50–99
- Employees
- 20–50M SEK
- Revenue
- 2004
- Founded
Key Decision Makers
Peter Zerhouni
Chief Financial Officer and Chief Business Officer
David Bejker
President and Chief Executive Officer
Mathias Uhlén
Board Director
Anders Martin-Löf
Board Director
+11 more contacts in Funnelfeedr
Description
Affibody is a specialized biotechnology company focused on creating next-generation radiopharmaceuticals. They leverage their proprietary Affibody® platform to develop radioligand therapeutics (RLTs) designed for precision targeting. The company strategically focuses its pipeline on major cancer typ...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556665691301
Decision Makers
15 contacts in FunnelfeedrPeter Zerhouni
Chief Financial Officer and Chief Business Officer
David Bejker
President and Chief Executive Officer
Mathias Uhlén
Board Director
Anders Martin-Löf
Board Director
Jakob Lindberg
Board Director
Guido Wuerth
Head Corporate Development, Radiopharma
Karin Nord
Senior Vice President Research Operations
Fredrik Frejd
Chief Scientific Officer
Rachel Humphrey
Board Director
Robert Burns
Chair of the Board
Michael Monaghan
Board Director (Employee Representative)
Rezan Güler
Board Director (Employee Representative)
Filippa Stenberg
Board Director
Gillian M Cannon
Board Director
Jonathan Knowles
Board Director
Similar Companies
20 similar companies in FunnelfeedrAffibody Medical AB
Developing next-generation radiopharmaceuticals using proprietary Affibody platform.
AAX Biotech AB
5–9 employeesResearch-driven biotech advancing antibody therapies via proprietary technology.
ZEALAND PHARMA A/S
0 employeesDeveloping peptide medicines for metabolic health challenges globally.
Oblique Therapeutics AB (publ)
10–19 employeesInnovative biotech developing breakthrough antibodies using the AbiProt platform.
Oncopeptides AB
20–49 employeesDeveloping targeted cancer therapies for difficult-to-treat diseases.
Browse More
Affibody AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo